Skip to Content

WATSON 491 150 mg (Mexiletine Hydrochloride 150 mg)

Pill with imprint WATSON 491 150 mg is Brown, Capsule-shape and has been identified as Mexiletine hydrochloride 150 mg. It is supplied by Watson Laboratories, Inc..

Mexiletine is used in the treatment of ventricular tachycardia; arrhythmia; myotonia congenita; diabetic peripheral neuropathy and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 491 150 mg

Mexiletine hydrochloride

WATSON 491 150 mg
150 mg
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.